Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
BMC Gastroenterology
|
October 23, 2019
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma
Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 16, 2025
Initial Experience With Nalmefene in Alcohol-Related Liver Disease: A Real-World Retrospective Study
Junichi Hanatani, Tadashi Namisaki, Hiroaki Takaya, et al.
Anticancer Research
|
October 3, 2022
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
Yuki Fujimoto, Tadashi Namisaki, Soichi Takeda, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis
Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, et al.
International Journal of Molecular Sciences
|
October 16, 2025
Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD
Masafumi Oyama, Tadashi Namisaki, Akihiko Shibamoto, et al.
United European Gastroenterology Journal
|
November 3, 2018
von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C
Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 13, 2026
Impact of the Number of Remaining Natural Teeth on Decompensation and Survival in Patients With Compensated Liver Cirrhosis
Tatsuya Nakatani, Tadashi Namisaki, Hiroaki Takaya, et al.
International Journal of Molecular Sciences
|
August 8, 2020
Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis
Yukihisa Fujinaga, Hideto Kawaratani, Daisuke Kaya, et al.
Current Issues in Molecular Biology
|
February 27, 2026
Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response
Aritoshi Koizumi, Tadashi Namisaki, Akihiko Shibamoto, et al.
Journal of Clinical Medicine
|
November 13, 2021
The Combination of Albumin-Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child-Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
Hiroaki Takaya, Tadashi Namisaki, Soichi Takeda, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
BMC Gastroenterology
|
October 23, 2019
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma
Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 16, 2025
Initial Experience With Nalmefene in Alcohol-Related Liver Disease: A Real-World Retrospective Study
Junichi Hanatani, Tadashi Namisaki, Hiroaki Takaya, et al.
Anticancer Research
|
October 3, 2022
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
Yuki Fujimoto, Tadashi Namisaki, Soichi Takeda, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis
Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, et al.
International Journal of Molecular Sciences
|
October 16, 2025
Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD
Masafumi Oyama, Tadashi Namisaki, Akihiko Shibamoto, et al.
United European Gastroenterology Journal
|
November 3, 2018
von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C
Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 13, 2026
Impact of the Number of Remaining Natural Teeth on Decompensation and Survival in Patients With Compensated Liver Cirrhosis
Tatsuya Nakatani, Tadashi Namisaki, Hiroaki Takaya, et al.
International Journal of Molecular Sciences
|
August 8, 2020
Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis
Yukihisa Fujinaga, Hideto Kawaratani, Daisuke Kaya, et al.
Current Issues in Molecular Biology
|
February 27, 2026
Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response
Aritoshi Koizumi, Tadashi Namisaki, Akihiko Shibamoto, et al.
Journal of Clinical Medicine
|
November 13, 2021
The Combination of Albumin-Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child-Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
Hiroaki Takaya, Tadashi Namisaki, Soichi Takeda, et al.
Page
of 11